The Manufacturers Life Insurance Company Has $39.37 Million Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

The Manufacturers Life Insurance Company raised its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 8.1% in the 3rd quarter, HoldingsChannel reports. The firm owned 540,089 shares of the company’s stock after buying an additional 40,625 shares during the period. The Manufacturers Life Insurance Company’s holdings in Henry Schein were worth $39,372,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also added to or reduced their stakes in the company. Cromwell Holdings LLC increased its holdings in shares of Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after acquiring an additional 170 shares in the last quarter. Summit Securities Group LLC bought a new stake in Henry Schein during the second quarter worth $31,000. Beach Investment Counsel Inc. PA bought a new stake in Henry Schein during the second quarter worth $37,000. Blue Trust Inc. grew its stake in Henry Schein by 104.2% in the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after purchasing an additional 475 shares during the period. Finally, Farther Finance Advisors LLC grew its stake in Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after purchasing an additional 346 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Insider Buying and Selling

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. This represents a 22.65 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now directly owns 87,706 shares in the company, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of research analysts have issued reports on HSIC shares. Robert W. Baird reduced their price objective on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. JPMorgan Chase & Co. reduced their price objective on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research note on Monday, August 12th. Evercore ISI upped their price objective on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Finally, UBS Group reduced their price objective on Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. Six analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $79.38.

Henry Schein Stock Up 0.5 %

Shares of NASDAQ HSIC opened at $77.66 on Friday. Henry Schein, Inc. has a one year low of $63.67 and a one year high of $82.63. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The business’s fifty day moving average price is $71.26 and its 200-day moving average price is $69.84. The stock has a market capitalization of $9.68 billion, a PE ratio of 31.96, a P/E/G ratio of 2.20 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. The business had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm’s quarterly revenue was up .4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.32 EPS. On average, equities research analysts anticipate that Henry Schein, Inc. will post 4.78 EPS for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.